Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detemir versus glargine for weight gain in adolescent females with type 1 diabetes
ISRCTN49492872Phase 3Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial in diabetes mellitus type 1 (T1D) comparing Levemir arm with Lantus arm (2 arms). Primary endpoint: Reduced weight gain. Started Apr 2008; status: completed.
02
Drugs
insulin detemirinsulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ISRCTN49492872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN49492872.